Related Experiment Video

Updated: Aug 16, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Mutant KRAS, chromosomal instability and prognosis in colorectal cancer

Patrizio Castagnola1, Walter Giaretti

  • 1National Institute for Cancer Research, Largo R. Benzi, 10, 16132-Genoa, Italy.

Biochimica Et Biophysica Acta
|August 23, 2005
PubMed

Insights

RAS mutations in colorectal cancer are controversial. This review examines their link to chromosomal instability and patient prognosis, impacting cell survival and metastasis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The RAS gene family encodes GTP-binding proteins that regulate gene expression, acting as molecular switches.
  • Mutant RAS proteins exhibit constitutive activation, unlike wild-type proteins, leading to downstream effector pathway dysregulation.
  • RAS pathway alterations are implicated in cancer development, influencing cell survival, apoptosis, angiogenesis, invasion, and metastasis.

Purpose of the Study:

  • To review the controversial association between KRAS mutations and chromosomal instability in colorectal cancer.
  • To investigate the impact of KRAS mutations on patient prognosis in colorectal cancer.

Main Methods:

  • Literature review of studies investigating KRAS mutations in colorectal cancer.
  • Analysis of the relationship between KRAS mutations, chromosomal instability, and patient outcomes.
  • Synthesis of current evidence on the role of RAS signaling in colorectal cancer progression.

Main Results:

  • KRAS mutations are frequently observed in colorectal cancer.
  • The precise role of KRAS mutations in driving chromosomal instability remains debated.
  • Evidence suggests a complex interplay between KRAS mutations, tumor progression, and patient prognosis.

Conclusions:

  • KRAS mutations represent a significant area of research in colorectal cancer.
  • Further investigation is needed to clarify the link between KRAS mutations, chromosomal instability, and therapeutic strategies.
  • Understanding these interactions is crucial for improving patient outcomes in colorectal cancer.

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...